Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID-HIG for COVID-19
NCT05173441Phase 2Unknown
- Sponsor
- Sinopharm Wuhan Biopharmaceuticals Co., Ltd.
- Start
- Dec 2021
- Primary completion
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of anti-COVID-19 immune globulin in coronavirus disease 2019 (COVID-19), sponsored by Sinopharm Wuhan Biopharmaceuticals Co., Ltd.. Status: unknown.
02
Drugs
anti-COVID-19 immune globulin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05173441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05173441.